Navigation Links
Study confirms prognostic value of new IASLC/ATS/ERS adenocarcinoma sub-classification
Date:12/15/2012

DENVER The International Association for the Study of Lung Cancer (IASLC), the American Thoracic Society (ATS), and the European Respiratory Society (ERS), have proposed a new sub-classification of lung adenocarcinomas. A growing number of publications from Australia, Germany and South America have validated the new sub-classification. However, there are only few reports of this type of validation for the Asian population. A new study published in the January 2013 issue of the International Association for the Study of Lung Cancer's (IASLC) Journal of Thoracic Oncology, concludes the new IASLC/ATS/ERS classification identifies histologic subtypes of lung adenocarcinomas with prognostic value among Japanese patients.

Researchers looked at patients with lung adenocarcinoma who underwent pulmonary resection between January 2001 and December 2009 at Kyoto University Hospital, Japan. The histological investigation included 440 lung adenocarcinomas, which met the 2004 WHO criteria for primary lung adenocarcinoma. Tumor staging was performed according to the 7th edition of the tumor, node, metastasis classification of the International Union Against Cancer.

Researchers concluded that the new classification identifies histologic subtypes of lung adenocarcinomas with prognostic value among Japanese patients. Moreover, they say, "EGFR mutations were significantly identified in AIS/MIA/Lepidic/Pap subtypes. Conversely, KRAS mutations were frequently identified in mucinous subtypes."

On the basis of these findings, they conclude, "that histologic subtyping and molecular testing for EGFR and KRAS mutations are helpful for predicting prognosis among patients with resectable lung cancer and may be helpful in selecting patients who require adjuvant chemotherapy."

The lead author of this work is Dr. Akihiko Yoshizawa. Co-authors include IASLC members Dr. Masashi Kobayashi, Dr. William Travis and Dr. Hiroshi Date.


'/>"/>

Contact: Kristal Griffith
Kristal.Griffith@iaslc.org
720-325-2952
International Association for the Study of Lung Cancer
Source:Eurekalert

Page: 1

Related biology news :

1. Study shows immunohistochemistry is reliable screening tool for ALK rearrangement
2. Study fuels insight into conversion of wood to bio-oil
3. Warming climate unlikely to cause extinction of ancient Amazon trees, study finds
4. University of Illinois receives grant to study ozone resistance in corn
5. OU study suggests the bacterial ecology that lives on humans has changed in the last 100 years
6. Study sheds light on how cells transport materials along crowded intercellular highways
7. Scientists develop novel method to study parasite numbers in wild seabirds
8. Mercyhurst University study probes impact of climate change on ectotherms
9. U of M to lead international virtual institute studying climatic and human effects on Earth
10. Fish have enormous nutrient impacts on marine ecosystems, study finds
11. UT study: Students who are more physically fit perform better academically
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/21/2017)... Der weltweite Biobanking-Sektor wird bis zum Jahr 2018 ... mehr als 50 Vertretern aus verschiedenen Branchen wurde aber klar, ... Prognose zu realisieren. ... Zu den Schwierigkeiten für Biobanking-Profis ... die Biobank, die Implementierung Zeit sparender Technologien, ein besseres ...
(Date:2/10/2017)... Research and Markets has announced the addition of ... Commercial Aspects" to their offering. ... Biomarkers play an important ... selection of treatment as well for monitoring the results. There ... modern medicine. Biochip/microarray technologies and next generation sequencing are also ...
(Date:2/8/2017)... 2017 The biometrics market has reached ... of organizations, desires to better authenticate or identify ... and challenge questions), biometrics is quickly working its ... market is driven by use cases, though there ... enterprise uses cases, with consumer-facing use cases encompassing ...
Breaking Biology News(10 mins):
(Date:2/23/2017)... DIEGO , Feb. 23, 2017 ... research tools, announced the acquisition of GenWay Biotech ... a comprehensive service and product offering for both ... acquisition will facilitate growth and enhance capabilities for ... antibodies, and ELISA assays will nicely complement ASB,s ...
(Date:2/23/2017)... ... February 22, 2017 , ... Seventy-one members ... named Fellows of the Society this year, the Fellows Committee has announced. The ... of optics, photonics, and imaging as well as their service to the Society ...
(Date:2/22/2017)... ... February 22, 2017 , ... ... Kendall Research Systems, LLC (KRS) clinical development program. KRS is a ... technology for research and clinical applications. The terms of the transaction were not ...
(Date:2/22/2017)...  PrimeVax Immuno-Oncology, Inc. announced today its CEO, ... Biocom Global Life Science Partnering Conference.  The presentation will ... the Torrey Pines Lodge, in San Diego.  ... who have chosen our company, amongst numerous others, to ... and clinical researchers," said Mr. Chen. "In contrast to ...
Breaking Biology Technology: